| Deborah Jean Ruxer, RN, MS, CNM | |
|
2222 Philadelphia Dr, Good Samaritan Hospital, The Family Birthing Center, Dayton, OH 45406-1813 | |
| (937) 278-2612 | |
| (937) 223-9735 |
| Full Name | Deborah Jean Ruxer |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 2222 Philadelphia Dr, Dayton, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326268624 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | NM-08809 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Deborah Jean Ruxer, RN, MS, CNM 8800 Windbluff Pt, Centerville Finance, OH 45458-2855 Ph: (937) 294-5203 | Deborah Jean Ruxer, RN, MS, CNM 2222 Philadelphia Dr, Good Samaritan Hospital, The Family Birthing Center, Dayton, OH 45406-1813 Ph: (937) 278-2612 |
News Archive
Jennerex, Inc., a private, clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic immunotherapies, today announced that the first patient has been treated in a Phase 2 clinical trial of intravenous treatment with JX-594 for patients with advanced hepatocellular carcinoma (HCC), or liver cancer, who have not received treatment with sorafenib—the current standard of care for this patient population.
Two daily doses of a probiotic lowered key cholesterol-bearing molecules in the blood as well as "bad" and total cholesterol, in a study presented at the American Heart Association's Scientific Sessions 2012.
Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced the initiation of a Phase 1b study designed to evaluate the safety of MP4CO treatment in patients with sickle cell disease.
Research shows that vitamin D supplementation and cow's milk intake have the greatest influence on 25–hydroxyvitamin D levels in healthy children aged 1–5 years.
Indevus Pharmaceuticals and Valera Pharmaceuticals have announced the completion of their previously announced merger, which became effective at 12:01 a.m., April 18, 2007.
› Verified 2 days ago
Carla Renee King, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 9000 N Main St, Suite 232, Dayton, OH 45415 Phone: 937-277-8988 Fax: 937-277-9035 | |
Jalana N Lazar, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 9000 N Main St, Suite 234, Dayton, OH 45415 Phone: 937-277-8988 Fax: 937-832-2421 | |
Donna M Gau-jata, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 1 Wyoming St, Dayton, OH 45409 Phone: 937-208-2007 | |
Mrs. Kimberly J Breneman, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 9000 N Main St, Suite 234, Dayton, OH 45415 Phone: 937-277-8988 Fax: 937-832-2421 | |
Dr. Shenika Ashley Zarebski, DO Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 30 E Apple St Ste 6258, Dayton, OH 45409 Phone: 937-208-8000 | |
Susan L Kloth, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 9000 N Main St, Suite 232, Dayton, OH 45415 Phone: 937-277-8988 Fax: 937-277-9035 |